Company Filing History:
Years Active: 2010
Title: Ruth T TenBrink: Innovator in Alzheimer's Disease Research
Introduction
Ruth T TenBrink is a notable inventor based in Labadie, MO (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target Alzheimer's disease.
Latest Patents
Ruth holds a patent for "Acetyl 2-hydroxy-1, 3-diaminoalkanes." This patent discloses compounds that are inhibitors of the beta-secretase enzyme. These compounds are useful in the treatment of Alzheimer's disease and other conditions characterized by the deposition of A beta peptide in mammals. She has 1 patent to her name.
Career Highlights
Ruth is associated with Elan Pharmaceuticals, Inc., where she has been instrumental in advancing research related to Alzheimer's disease. Her work has contributed to the understanding and potential treatment of this debilitating condition.
Collaborations
Ruth has collaborated with notable colleagues, including Varghese John and Michel Maillard. Their combined expertise has furthered the research efforts in the pharmaceutical industry.
Conclusion
Ruth T TenBrink's innovative work in the field of Alzheimer's research highlights her dedication to improving the lives of those affected by this disease. Her contributions are invaluable to the ongoing fight against Alzheimer's disease.